書誌事項
- タイトル別名
-
- Basic and clinical studies on pazufloxacin in otorhinolaryngological infections
この論文をさがす
抄録
A newly developed oral quinolone, pazufloxacin (PZFX), was used in infections in the field of otorhinolaryngology, and its usefulness, safety and pharmacokinetics were studied.<BR>Prior to surgery, 200mg of PZFX was orally administered to 20 patients with chronic sinusitis, chronic otitis media and tonsillitis, and their plasma and tissue levels were determined 2-9 hours later.<BR>The clinical study was performed in 61 patients including 16 with otitis media (5 acute, 11 chronic acute exacerbation), 17 with sinusitis (14 acute, 3 chronic acute exacerbation), 19 with tonsillitis, 4 with pharyngitis and 5 with acute external otitis. The drug was orally administered at a single dose of 100-200mg 2-3 times a day (daily dose, 300-600mg) for 2-15 days.<BR>In pharmacokinetic study, maximum levels (1.43-2.10μg/ml) in plasma were observed 2-3 hours after administration of PZFX, and then declined gradually. The tissue concentration in the middle ear reached 0.16-1.3μg/g 2-9 hours after administration. In the clinical study, 13 of 61 patients were excluded: 9 who did not come to the hospital, 1 in whom the drug was withdrawn because of side effects, 1 in whom a prohibited drug was used concomitantly, and 2 with other diseases. Therefore, the clinical effect was determined in 48 patients. Efficacy rates were 91.7% (11/12) in otitis media, 85.7% (12/14) in sinusitis, 68.8% (11/16) in tonsillitis, 4/4 in pharyngitis and 2/2 in external otitis, a total efficacy rate of 83.3%. Bacteriologically, 30 of 32 strains of gram-positive organisms and 6 of 7 strains of gramnegative organisms were eradicated, an eradication rate of 90.2% (37/41).<BR>Adverse effects, diarrhea was observed in 1 of 59 patients studied, and the laboratory findings showed elevation of GPT in 1 of 37 patients tested.<BR>The results suggest that PZFX is a useful antimicrobial agent for the treatment of otorhinolaryngological infections.
収録刊行物
-
- 日本化学療法学会雑誌
-
日本化学療法学会雑誌 43 (Supplement2), 473-482, 1995
公益社団法人 日本化学療法学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681263760512
-
- NII論文ID
- 10005466976
-
- NII書誌ID
- AN10472127
-
- ISSN
- 18845886
- 13407007
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可